ConductScience.org, home

Paper3980561

Survival of human bone marrow cells after in vitro treatment with 12 anticancer drugs and implications for tumor drug sensitivity assays.

Umbach GE and 6 others. J Cancer Res Clin Oncol, 1985. Cited by 9 papers, by iCite.

Cite this record

ConductScience Library. Survival of human bone marrow cells after in vitro treatment with 12 anticancer drugs and implications for tumor drug sensitivity assays. Papers, record 3980561. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3980561

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Survival of human bone marrow cells after in vitro treatment with 12 anticancer drugs and implications for tumor drug sensitivity assays.
PubMed
Journal
J Cancer Res Clin Oncol
PubMed
Year
1985
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
9
iCite
Relative citation ratio, by iCite
0.46
iCite
Revised in PubMed
2026-09-25
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Umbach GEG E
2Hug VV
3Spitzer GG
4Tomasovic BB
5Thames HH
6Ajani JAJ A
7Drewinko BB

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antineoplastic AgentsMajor topic
Bone MarrowMajor topic
Colony-Forming Units AssayMajor topic
Tumor Stem Cell AssayMajor topic
Cell Survival
Dose-Response Relationship, Drug
Hematopoietic Stem Cells
Humans

Source PubMed

Download CSV of topics

Grants4

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
CA 14528NCI NIH HHSUnited StatesP01CA014528PubMed and NIHNIH RePORTER
CA 23272NCI NIH HHSUnited StatesR01CA023272PubMed and NIHNIH RePORTER
CA 28153NCI NIH HHSUnited StatesP01CA028153PubMed and NIHNIH RePORTER
P02CA014528NIHNIH RePORTER

Download CSV of grants

References21

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
17318145Potentials and possible pitfalls of human stem cell analysis.Cancer Chemother Pharmacol1981https://conductscience.org/library/papers/7318145PubMed
24125097The sensitivity to bleomycin of spleen colony forming units in the mouse.Br J Cancer1973https://conductscience.org/library/papers/4125097PubMed
369510715-Fluorouracil, 1,3-bis(2-chloroethyl)-1-nitrosourea, and 1-(2-chloroethyl)-3-(4-methylcyclohexyl)-1-nitrosourea: effect on the human granulopoietic system.J Natl Cancer Inst1982https://conductscience.org/library/papers/6951071PubMed
46572563Clinical correlations of leukemic clonogenic cell chemosensitivity assessed by in vitro continuous exposure to drugs.Cancer Res1983https://conductscience.org/library/papers/6572563PubMed
51087180The reversal of methotrexate cytotoxicity to mouse bone marrow cells by leucovorin and nucleosides.Cancer Res1976https://conductscience.org/library/papers/1087180PubMed
67193870In vitro drug assay: pharmacologic considerations.Prog Clin Biol Res1980https://conductscience.org/library/papers/7193870PubMed
76838146Clinical application of the clonogenic assay.Ann Clin Lab Sci1983https://conductscience.org/library/papers/6838146PubMed
8387224cis-Dichlorodiammineplatinum(II) for the treatment of advanced ovarian cancer.Cancer Treat Rep1979https://conductscience.org/library/papers/387224PubMed
94113143The response of human lymphoma cells in vitro to bleomycin and 1,3-bis(2-chloroethyl)-1-nitrosourea.Cancer Res1972https://conductscience.org/library/papers/4113143PubMed
1016398024Colony stimulating factor augmentation in human placental conditioned medium.Exp Hematol1980https://conductscience.org/library/papers/16398024PubMed
11734053Radiobiological techniques applied to environmental problems.Radiat Res1978https://conductscience.org/library/papers/734053PubMed
126891626Human tissue distribution of platinum after cis-diamminedichloroplatinum.Cancer Chemother Pharmacol1982https://conductscience.org/library/papers/6891626PubMed
136837681Soft agar colony formation assay for in vitro testing of sensitivity to chemotherapy of gynecologic malignancies.Am J Obstet Gynecol1983https://conductscience.org/library/papers/6837681PubMed
14640566[Testing the resistance of human tumor and bone marrow cells to cytostatic agents].Fortschr Med1978https://conductscience.org/library/papers/640566PubMed
156339044Prospective clinical trial of a human tumor cloning system.Cancer Res1983https://conductscience.org/library/papers/6339044PubMed
166339049Radiation sensitivity of leukemic progenitor cells in acute nonlymphocytic leukemia.Cancer Res1983https://conductscience.org/library/papers/6339049PubMed
176692414Normalization of in vitro sensitivity testing of human tumor clonogenic cells.Cancer Res1984https://conductscience.org/library/papers/6692414PubMed
186683465Cis-platinum in the treatment of advanced or recurrent adenocarcinoma of the ovary. A phase II study of the Gynecologic Oncology Group.Am J Clin Oncol1983https://conductscience.org/library/papers/6683465PubMed
19594662Studies on the regeneration of the CFU-C population in blood and bone marrow of lethally irradiated dogs after autologous transfusion of cryopreserved mononuclear blood cells.Scand J Haematol1977https://conductscience.org/library/papers/594662PubMed
20749923Changes of granulopoiesis during and after adjuvant chemotherapy of breast cancer.Br J Haematol1978https://conductscience.org/library/papers/749923PubMed

See all 21 referencesDownload CSV of references

Cited by3

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 9 citations.

PMIDTitleJournalYearIn PapersSource
18596744Preferential sensitivity of hematopoietic (HPs) and mesenchymal (MPs) progenitors to fludarabine suggests impaired bone marrow niche and HP mobilization.Leukemia2008https://conductscience.org/library/papers/18596744PubMed
3778805In vitro cytotoxicity patterns of standard and investigational agents on human bone marrow granulocyte-macrophage progenitor cells.Br J Cancer1986https://conductscience.org/library/papers/3778805PubMed
2803923Potential therapeutic role of cisplatinum in autologous bone marrow transplantation: in vitro eradication of neuroblastoma cells from bone marrow.Br J Cancer1989https://conductscience.org/library/papers/2803923PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/3980561

GET https://conductscience.org/api/papers/v1/3980561/references?page=2